Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05995522
Other study ID # CI-00421
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date December 31, 2023

Study information

Verified date May 2024
Source University of Guadalajara
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare de effect of vitamin K2 in young adults with overweight or obesity. The main questions to answer are: What is the effect of Vitamin K2 supplementation on methylation, serum concentration of ucOC, cOC, Gas6, leptin, inflammatory markers, cardiometabolic risk factors, and cardiovascular risk in overweight or obese young adults? Participants will be assigned to one of two intervention groups where they will consume Vitamin K2 100 µg per day or cornstarch 500 mg per day for 90 days. If there is a comparison group: Investigators will compare the supplementation group (Vitamin K2) with the placebo group (cornstarch) to see if vitamin K2 supplementation modifies methylation, increases serum vitamin K, osteocalcin, growth arrest-specific 6 protein serum concentration, decreases serum leptin concentration, inflammatory markers and reduces cardiometabolic risk factors and cardiovascular risk.


Description:

Study Overview To meet the objectives of the project, two groups will be compared, one that will be supplemented with vitamin K and another of patients who will receive corn starch as a placebo. Patients are going to have a follow up during 3 months with periodic evaluations every 30 days. This is a double-blind study, it is achieved by maintaining similarities in appearance, taste and smell between the treatments that will be delivered in the same vials, with same number of pills and identical in shape, color and consistency for each study group. Patient recruitment will take place by disseminating information through physical and social media, once potential participants have been identified, they will be contacted and informed about the project, and if they decide to participate in the study, they will be asked to sign the informed consent. Simple randomization will be performed using R software to assign participants to one of the study groups. A clinical history, anthropometric measurements and blood sampling shall be applied. Nutritional recommendations based on the position of the Academy of Nutrition and Dietetics for the treatment of overweight and obesity and the healthy eating plate of Harvard University will be given. An appointment is to be scheduled every 30 days in order to provide the supplementation and follow-up. At the end, the pertinent statistical analyzes will be carried out. Notification of adverse effects will be made in each of the sessions, in addition to this the participants will have the contact of the researchers to notify any anomaly. Sample's size calculation The sample size was calculated using the statistical formula for the comparison of two means. This estimate was made using the following formula: n=2(Zα+Z[1-β]2xSD2/d2 Where: n= sample size required in each group SD= standard deviation of the effect Zα: to the value of Z for a confidence level of 95% Z[1-β}: to the value of Z for a statistical power of 80% D= effect size A total of 19.72 patients per group were obtained. Considering a 20% loss, 24 patients are needed per study group. Ethical considerations The study was approved by the Biosafety committee, research ethics committee and research committee of the University Center for Health Sciences, University of Guadalajara: CI-00421. The committees of the University have the authority to monitor and audit the study at any of its stages once it has been approved. Objetives General objective Evaluate the effect of vitamin K2 supplementation on methylation, the serum concentration of total vitamin K, osteocalcin, growth arrest-specific 6 protein, leptin, inflammatory markers, cardiometabolic risk factors and cardiovascular risk in young Mexican adults with overweight or obesity. Specific objectives 1. Compare the baseline variables between groups. 2. Compare the variable changes across the time within groups 3. Compare the variable changes across the time between groups Statistical analysis The Shapiro-Wilk normality test is performed to determine whether the analysis will require parametric or non-parametric tests. Qualitative variables will be expressed as frequencies and percentages, while quantitative variables will be expressed as mean and standard deviation in parametric data or medians and ranges in non-parametric data. Specific objective 1 Statistical technique T-student for independent samples if it has a normal distribution or by U-Mann Whitney for independent samples if it does not have a normal distribution Specific objective 2 Variables with two measures Statistical technique T-student for paired samples if it has a normal distribution or the Wilcoxon signed-rank test if it does not have a normal distribution Variables with more than two measures Statistical technique Repeated measures ANOVA if it has a normal distribution or the Friedman Test if it does not have a normal distribution Specific objective 3 Statistical technique The effect size of the groups is compared with T-student for independent samples if it has a normal distribution or by U-Mann Whitney for independent samples if it does not have a normal distribution


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date December 31, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Body Mass Index greater than 25 kg/m2 and less than 40 kg/m2 - That they agree to participate in the study voluntarily and informed and sign the informed consent Exclusion Criteria: - People with self-reported diagnosis of chronic kidney, gastrointestinal or systemic disease - Use of bile acid sequestrants drugs, insulin, glucocorticoids, contraceptives, bisphosphonates, thiazides, levetiracetam, thiazolidinediones, anticoagulants or estrogenic drugs and vitamin D, vitamin K, vitamin A, vitamin E, omegas or calcium supplements - Patients who are on a hypocaloric or low-fat diet - Self-reported pregnancy

Study Design


Intervention

Dietary Supplement:
Vitamin K2
100 µg per day for 90 days
Other:
Cornstarch
500 mg per day for 90 days

Locations

Country Name City State
Mexico University of Guadalajara Guadalajara Jalisco

Sponsors (1)

Lead Sponsor Collaborator
University of Guadalajara

Country where clinical trial is conducted

Mexico, 

References & Publications (1)

Aguayo-Ruiz JI, Garcia-Cobian TA, Pascoe-Gonzalez S, Sanchez-Enriquez S, Llamas-Covarrubias IM, Garcia-Iglesias T, Lopez-Quintero A, Llamas-Covarrubias MA, Trujillo-Quiroz J, Rivera-Leon EA. Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial. Diabetol Metab Syndr. 2020 Aug 18;12:73. doi: 10.1186/s13098-020-00580-w. eCollection 2020. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Osteocalcin serum concentration ng/dL Baseline and after 90 days of intervention
Primary Vitamin K serum concentration ng/dL Baseline and after 90 days of intervention
Primary Leptin serum concentration ng/dL Baseline and after 90 days of intervention
Primary Tumour Necrosis Factor alpha serum concentration pg/mL Baseline and after 90 days of intervention
Primary Interleukin-1 Beta serum concentration pg/mL Baseline and after 90 days of intervention
Primary Interleukin-6 serum concentration pg/mL Baseline and after 90 days of intervention
Primary Interleukin-4 serum concentration pg/mL Baseline and after 90 days of intervention
Primary Interleukin-10 serum concentration pg/mL Baseline and after 90 days of intervention
Primary Cardiovascular risk percentage Baseline, after 30, 60 and 90 days of intervention
Primary LEP gene methylation Methylated or unmethylated Baseline and after 90 days of intervention
Secondary Growth arrest-specific 6 protein serum concentration ng/ml Baseline and after 90 days of intervention
Secondary Global methylation percentage Baseline and after 90 days of intervention
Secondary Atherogenic indices Value Baseline and after 90 days of intervention
Secondary Triglycerides serum concentration mg/dL Baseline and after 90 days of intervention
Secondary Total cholesterol serum concentration mg/dL Baseline and after 90 days of intervention
Secondary HDL cholesterol serum concentration mg/dL Baseline and after 90 days of intervention
Secondary LDL cholesterol serum concentration mg/dL Baseline and after 90 days of intervention
Secondary VLDL cholesterol serum concentration mg/dL Baseline and after 90 days of intervention
Secondary Glucose serum concentration mg/dL Baseline and after 90 days of intervention
Secondary Blood pressure mmHg Baseline, after 30, 60 and 90 days of intervention
Secondary Insulin serum concentration µIU/ml Baseline and after 90 days of intervention
Secondary Weight kg Baseline, after 30, 60 and 90 days of intervention
Secondary Body mass index kg/m2 Baseline, after 30, 60 and 90 days of intervention
Secondary Waist circumference cm Baseline, after 30, 60 and 90 days of intervention
Secondary Hip circumference cm Baseline, after 30, 60 and 90 days of intervention
Secondary Fat mass kg Baseline, after 30, 60 and 90 days of intervention
Secondary % fat percentage Baseline, after 30, 60 and 90 days of intervention
Secondary Lean mass kg Baseline, after 30, 60 and 90 days of intervention
Secondary Estimated energy consumption kcal/day Baseline, after 30, 60 and 90 days of intervention
Secondary Estimated protein consumption grams/day Baseline, after 30, 60 and 90 days of intervention
Secondary Estimated carbohydrates consumption grams/day Baseline, after 30, 60 and 90 days of intervention
Secondary Estimated fat consumption grams/day Baseline, after 30, 60 and 90 days of intervention
Secondary Estimated vitamin K consumption µg/day Baseline, after 30, 60 and 90 days of intervention
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A